Abstract 1244: The requirement of autophagy pathway for drug-induced senescence in human melanoma cells by AZD1152
作者
Gao Zhang,Meenhard Herlyn
出处
期刊:Cancer Research [American Association for Cancer Research] 日期:2011-04-01卷期号:71 (8_Supplement): 1244-1244
标识
DOI:10.1158/1538-7445.am2011-1244
摘要
Abstract Oncogene-induced senescence (OIS) is a well-documented phenomenon both in vitro and in vivo as a tumor-suppression mechanism. It functions as a barrier to tumor initiation and progression. However, tumor cells quickly develop a sophisticated yet not well-understood mechanism to overcome and subsequently repress cellular senescence to facilitate its progression. Here we have focused on the drug-induced senescence in human melanoma cells by inhibition of Aurora B kinase (AURKB) through either small molecule AZD1152 or shAURKB. By implementing a systems biology approach, we have uncovered the necessity of mTOR, and autophagy/lysosome pathways for the drug-induced senescence in human melanoma cells. Particularly, the mTOR inhibitor Rapamycin suppresses the senescence phenotype by converting senescence to quiescence, whereas the autophagy inhibitor Bafilomycin A1 or Hydroxychloroquine can induce cell death in senescent melanoma cells induced by AZD1152, suggesting that autophagy is an important survival mechanism for senescent melanoma cells. Thus our study can potentially lead to a framework of utilizing the pro-senescence therapy followed by inhibition of autophagy as a novel clinic approach toward melanoma prevention and cure. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2011;71(8 Suppl):Abstract nr 1244. doi:10.1158/1538-7445.AM2011-1244